Abcam is committed to meeting high standards of ethical manufacturing and has decided to discontinue this product by June 2019 as it has been generated by the ascites method. We are sorry for any inconvenience this may cause. We would recommend antibodies ab214428 or ab125067 as replacements.
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Western blot - Anti-Cathepsin B antibody [CA10] (ab58802)
Immunocytochemistry/ Immunofluorescence - Anti-Cathepsin B antibody [CA10] (ab58802)Image from Shimizu A et al., The Journal of Biological Chemistry, 288, 2210-2222, January 25, 2013. Fig 5.; doi: 10.1074/jbc.M112.397398
Immunofluorescence analysis of U87MG cells incubated with netrin-1, staining Cathepsin B with ab58802.
Flow Cytometry - Anti-Cathepsin B antibody [CA10] (ab58802)
Overlay histogram showing HepG2 cells stained with ab58802 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab58802, 0.5µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin B antibody [CA10] (ab58802)Image courtesy of Dr Irina Teplova by Abreview.
ab58802 staining Cathepsin B in murine mammary gland tissue by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections). Tissue was fixed in formaldehyde and a heat mediated antigen retrieval step was performed using citrate buffer. Samples were then blocked and then incubated with ab58802 at a 1/200 dilution for 30 minutes at 22°C. The secondary used was a biotin conjugated rabbit anti-mouse monoclonal at a 1/250 dilution.
Hsu SPC et al. Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells. Oncotarget9:6883-6896 (2018).
Read more (PubMed: 29467937) »
Komura T et al. Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma. Cancer Sci108:2122-2129 (2017).
Read more (PubMed: 28898495) »